Zhejiang Rongmei Biopharmaceutical Technology Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Zhejiang Rongmei Biopharmaceutical Technology Co., Ltd. - overview
Established
2023
Location
Hangzhou, Zhejiang, China
Primary Industry
Biotechnology
About
Based in Hangzhou, China and founded in 2023, Zhejiang Rongmei Biopharmaceutical Technology Co. , Ltd. , dba Rongmei Bio, develops therapeutic candidates for neurodegenerative and lysosomal dysfunction diseases. The company aims to advance novel drug targets and contribute to global innovation in CNS and lysosomal biology drug development.
The company works with pharmaceutical partners, research institutions, and clinical developers to advance drug candidates targeting lysosomal ion channels and membrane transport proteins, providing early discovery research, target validation, and translational development. Its scientific team focuses on mechanistic biology, small-molecule therapeutic design, and preclinical evaluation for neurodegenerative disease pathways. The company generates revenue through research collaborations, drug-development partnerships, and milestone-based R&D service agreements with biopharma clients. In July 2025, Zhejiang Rongmei Biopharmaceutical Technology Co.
, Ltd. closed a venture funding from new investor Co-Win Ventures.
Current Investors
Co-Win Ventures
Primary Industry
Biotechnology
Sub Industries
Biotechnology
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.